PREVENTION OF PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION BY ALFPHA 1-ANTITRYPSIN TREATMENT: A RANDOMIZED, CONTROLLED, DOUBLE-BLINDED CLINICAL TRIAL

Registry ID

23-5745

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY HEALTH NETWORK

Last update

2025-02-27

Conditions

• LUNG TRANSPLANTATION

View on source registry